1 results match your criteria: "Bordeaux University and Bordeaux University Hospital[Affiliation]"
Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003.
Pediatr Blood Cancer
July 2010
Bordeaux University and Bordeaux University Hospital, Pediatric Oncology and Hematology Unit, 33076 Bordeaux, France.
Aim: To determine the epidemiology of myeloid leukaemia (ML) in children with Down syndrome (DS) and the efficacy of two approaches, low-dose cytarabine-based regimen (LDC) and standard-dose intensive chemotherapy (SD).
Procedure: All children with Down syndrome aged from 2 months to 15 years with ML/myelodysplasia registered in the French registry between January 1990 and December 2003 were included.
Results: Forty-four patients were included.